Aiforia Technologies Plc, Press Release, July 23, 2024 at 01:00 p.m. EEST
The regional health management of Castile and León in Spain has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics. The contract is part of a tender with an initiative to improve the diagnostic workflow of the region's pathology laboratories, including, for example, an image management system provided by Sectra combined with AI solutions for image analysis by Aiforia.
The collaboration involves the use of selected Aiforia Clinical AI solutions for the analysis of tissue samples, e.g., from breast, prostate, and lung cancer patients. The total value of the contract for Aiforia is approximately EUR 500 thousand for three years.
“We are excited to announce this large clinical project in Spain. This partnership represents a significant milestone for our company as we expand our footprint in Europe, reinforcing our commitment to delivering innovative solutions and unparalleled value to our customers. We are also pleased to collaborate with Sectra on this account and combine our offerings to support the region in improving their diagnostic workflows,” says Jukka Tapaninen, CEO of Aiforia.
Certified Adviser
UB Securities Ltd, ubs@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more: www.aiforia.com
Back to all blog posts
